Atomoxetine

Sold as Strattera, Inir, Attentra, Concitron, Atomoxetine austell, Straxet, Norblok, Atastrat, Attentus, Pellego, Stradent, Atoxtrin

C₁₇H₂₁NO255.35 g/mol

(3R)-N-Methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine

Drag to rotate. Structure from PubChem CID 54841.

Loading Wikipedia summary

Registration

Applicants: 9
Registrations: 55
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Eli Lilly (S.A.) (Pty) LtdCancelled	Strattera	10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg	420789, A380520, A380521, A380522, A380523, A380524	S5	None
Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd.	Inir	10, 18, 25, 40, 60	430809, 430810, 430811, 430812, 430813	S5	PI PIL
Teva Pharmaceuticals (Pty) Ltd	Attentra	25	500593	S5	PI PIL
Austell Pharmaceuticals (Pty) Ltd11 of 12 cancelled	Concitron, Atomoxetine austell	10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg	509002, 509003, 509004, 509005, 509006, 509007, 509008.002, 509009.003, 509010.004, 509011.005, 509012.006, 509013.007	S5	None
Pharma Dynamics (Pty) LtdCancelled	Straxet	10 mg	510383.376	S5	None
Pharmacare limited û woodmeadCancelled	Norblok	10 mg, 18 mg, 25 mg, 40 mg, 60 mg	510482, 510483, 510484, 510485, 510486	S5	None
Sandoz South Africa (Pty) LtdCancelled	Atastrat	10, 18, 25, 40, 60, 80	520976, 520977.97, 520978.971, 520979.972, 520980.973, 520981.974	S5	None
Aurogen South Africa (Pty) Ltd4 of 13 cancelled	Attentus, Pellego, Stradent	10 mg, 18 mg, 25 mg, 40 mg, 60 mg	530028, 530029, 530030, 530031, 530032, 530033.028, 530034.029, 530035.03, 530037.032, 530038.028, 530039.029, 530040.03, 530042.032	S5	None
Trinity Pharma (Pty) Ltd	Atoxtrin	10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg	550743, 550744, 550745, 550746, 550747, 550748	S5	PI PIL

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Strattera 80 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg	80 mg	42078942/1.2/0789	Cancelled	S5	None
Inir 10 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg	10Capsule	43080943/1.2/0809Approved 26 March 2026	Registered	S5	PI PIL
Inir 18 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg	18Capsule	43081043/1.2/0810Approved 26 March 2026	Registered	S5	PI PIL
Inir 25 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25Capsule	43081143/1.2/0811Approved 26 March 2026	Registered	S5	PI PIL
Inir 40 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg	40Capsule	43081243/1.2/0812Approved 26 March 2026	Registered	S5	PI PIL
Inir 60 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg	60Capsule	43081343/1.2/0813Approved 26 March 2026	Registered	S5	PI PIL
Attentra 25 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25Capsules	50059350/1.2/0593Approved 9 July 2025	Registered	S5	PI PIL
Concitron 10 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg	10 mg	50900250/1.2/9002	Cancelled	S5	None
Concitron 18 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg	18 mg	50900350/1.2/9003	Cancelled	S5	None
Concitron 25 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25 mg	50900450/1.2/9004	Cancelled	S5	None
Concitron 40 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg	40 mg	50900550/1.2/9005	Registered	S5	None
Concitron 60 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg	60 mg	50900650/1.2/9006	Cancelled	S5	None
Concitron 80 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg	80 mg	50900750/1.2/9007	Cancelled	S5	None
Atomoxetine 10 MG austell EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg	10 mg	509008.00250/1.2/9008.002	Cancelled	S5	None
Atomoxetine 18 MG austell EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg	18 mg	509009.00350/1.2/9009.003	Cancelled	S5	None
Atomoxetine 25 MG austell EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25 mg	509010.00450/1.2/9010.004	Cancelled	S5	None
Atomoxetine 40 MG austell EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg	40 mg	509011.00550/1.2/9011.005	Cancelled	S5	None
Atomoxetine 60 MG austell EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg	60 mg	509012.00650/1.2/9012.006	Cancelled	S5	None
Atomoxetine 80 MG austell EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg	80 mg	509013.00750/1.2/9013.007	Cancelled	S5	None
Straxet 10 MG Each capsule contains: Atomoxetine Hydrochloride Equivalent to Atomoxetine 10,0 mg	10 mg	510383.37651/1.2/0383.376	Cancelled	S5	None
Norblok 10 MG Each capsules contains: Atomoxetine Hydrochloride Equivalent to Atomoxetine 10 mg	10 mg	51048251/1.2/0482	Cancelled	S5	None
Norblok 18 MG Each capsules contains: Atomoxetine Hydrochloride Equivalent to Atomoxetine 18 mg	18 mg	51048351/1.2/0483	Cancelled	S5	None
Norblok 25 MG Each capsule contains: Atomoxetine Hydrochloride Equivalent to Atomoxetine 25,0 mg	25 mg	51048451/1.2/0484	Cancelled	S5	None
Norblok 40 MG Each capsule contains: Atomoxetine Hydrochloride Equivalent to Atomoxetine 40,0 mg	40 mg	51048551/1.2/0485	Cancelled	S5	None
Norblok 60 MG Each capsule contains: Atomoxetine Hydrochloride Equivalent to Atomoxetine 60,0 mg	60 mg	51048651/1.2/0486	Cancelled	S5	None
Atastrat 10 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg	10	52097652/1.2/0976	Cancelled	S5	None
Atastrat 18 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg	18	520977.9752/1.2/0977	Cancelled	S5	None
Atastrat 25 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25	520978.97152/1.2/0978	Cancelled	S5	None
Atastrat 40 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg	40	520979.97252/1.2/0979	Cancelled	S5	None
Atastrat 60 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg	60	520980.97352/1.2/0980	Cancelled	S5	None
Atastrat 80 EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg	80	520981.97452/1.2/0981	Cancelled	S5	None
Attentus 10 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg	10 mg	53002853/1.2/0028	Registered	S5	None
Attentus 18 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg	18 mg	53002953/1.2/0029	Registered	S5	None
Attentus 25 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25 mg	53003053/1.2/0030	Registered	S5	None
Attentus 40 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg	40 mg	53003153/1.2/0031	Registered	S5	None
Attentus 60 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg	60 mg	53003253/1.2/0032	Registered	S5	None
Pellego 10 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg	10 mg	530033.02853/1.2/0033/028	Cancelled	S5	None
Pellego 18 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg	18 mg	530034.02953/1.2/0034.029	Cancelled	S5	None
Pellego 25 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25 mg	530035.0353/1.2/0035.030	Cancelled	S5	None
Pellego 60 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg	60 mg	530037.03253/1.2/0037.032	Cancelled	S5	None
Stradent 10 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg	10 mg	530038.02853/1.2/0038.028	Registered	S5	None
Stradent 18 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg	18 mg	530039.02953/1.2/0039.029	Registered	S5	None
Stradent 25 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25 mg	530040.0353/1.2/0040.030	Registered	S5	None
Stradent 60 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg	60 mg	530042.03253/1.2/0042.032	Registered	S5	None
Atoxtrin 10 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg	10 mgCapsule	55074355/1.2/0743Approved 19 August 2025	Registered	S5	PI PIL
Atoxtrin 18 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg	18 mgCapsule	55074455/1.2/0744Approved 19 August 2025	Registered	S5	PI PIL
Atoxtrin 25 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25 mgCapsule	55074555/1.2/0745Approved 19 August 2025	Registered	S5	PI PIL
Atoxtrin 40 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg	40 mgCapsule	55074655/1.2/0746Approved 19 August 2025	Registered	S5	PI PIL
Atoxtrin 60 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg	60 mgCapsule	55074755/1.2/0747Approved 19 August 2025	Registered	S5	PI PIL
Atoxtrin 80 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg	80 mgCapsule	55074855/1.2/0748Approved 19 August 2025	Registered	S5	PI PIL
Strattera 10 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg	10 mg	A380520A38/1.2/0520	Cancelled	S5	None
Strattera 18 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg	18 mg	A380521A38/1.2/0521	Cancelled	S5	None
Strattera 25 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg	25 mg	A380522A38/1.2/0522	Cancelled	S5	None
Strattera 40 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg	40 mg	A380523A38/1.2/0523	Cancelled	S5	None
Strattera 60 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg	60 mg	A380524A38/1.2/0524	Cancelled	S5	None

Regulatory status

Where S5 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only, with tighter controls on repeats.

Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.

Consolidated Schedules listings for Atomoxetine hydrochloride equivalent to atomoxetine

S5: Atomoxetine
Consolidated Schedules 06 July 2026, line 9226

Pharmacological class: Psychoanaleptics (antidepressants). (class 1.2)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Inir 10, Dr Reddyæs Laboratories (Pty) Ltd is scheduled S5 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsInir 10, Dr Reddyæs Laboratories (Pty) Ltd Patient information leaflet (PIL)For patients and carersInir 10, Dr Reddyæs Laboratories (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background